Asia-Pacific Newborn Screening Market - Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Oct 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 109
  • No of Figures: 26

Asia-Pacific Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) - Industry Trends and Forecast to 2026

Asia-Pacific market for newborn screening is considered to be one of the most expanding markets in the global healthcare industry. Newborn screening is the testing that diagnoses harmful and fatal disorders in newborns which can adversely affect their long term health. The newborn screening tests can detect around thirty metabolic and genetic diseases and some common are phenylketonuria (PKU), congenital hypothyroidism (CH), galactosemia (GAL), and sickle cell disease. Increased government initiatives to aware people regarding newborn screening are playing a vital role in expansion of newborn screening market. Newborn screening is a mandatory test in over 60 countries including U.S., Australia, and New Zealand. These countries have an Infant Mortality Rate of less than 10 per 1000 births. However, in India, only less than 1.0% of infants are screened and every year over 1.6 million babies are born with birth defects.

Asia-Pacific newborn screening market is projected to register a healthy CAGR in the forecast period of 2019 to 2026.

SegmentationAsia-Pacific Newborn Screening Market

Asia-Pacific newborn screening market is segmented into five notable segments which are test type, product type, technology, disease type and end user.

  • On the basis of test type, the market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test
  • On the basis of product type, the market is segmented into instruments, reagents & assay kits
  • On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays
  • On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others
  • On the basis of end user, the market is segmented into pediatric clinics, hospital, clinics

Competitive Analysis: Asia-Pacific Newborn Screening Market

Some of the major players operating in the Asia-Pacific newborn screening market are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., among others.

Recent Developments

  • In May 2019, PerkinElmer Inc, helped parent project Muscular Dystrophy launch a screening program for newborns for muscular dystrophy. It helps the company in increasing market value and market share by creating awareness for newborn screening.
  • In February 2018, Vivosonic Inc. received regulatory approval fot Integrity V500 system from the State Food and Drug Administration (SFDA) of the People’s Republic of China in China. This approval expands the Vivosonics’ business in China.
  • In February 2018, Vivosonic Inc. received regulatory approval from the ministry of health, labour and welfare to market Integrity V500 system in Japan. This approval expands the business in Japan.

Research Methodology: Asia-Pacific Newborn Screening Market

Primary Respondents: Key Opinion Leaders (KOL’s): Doctors, Nurses, Research Institutes and Medical Professionals. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S.

TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018

TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016)

TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018)

TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018)

TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)

TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS

TABLE 9 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 10 ASIA-PACIFIC DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 ASIA-PACIFIC HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 ASIA-PACIFIC CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 14 ASIA-PACIFIC PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 ASIA-PACIFIC INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 16 ASIA-PACIFIC REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 18 ASIA-PACIFIC TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 ASIA-PACIFIC HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 ASIA-PACIFIC PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 ASIA-PACIFIC IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 ASIA-PACIFIC ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 ASIA-PACIFIC DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 25 ASIA-PACIFIC CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 ASIA-PACIFIC NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 ASIA-PACIFIC SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 ASIA-PACIFIC PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 ASIA-PACIFIC CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 ASIA-PACIFIC OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 33 ASIA-PACIFIC HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 ASIA-PACIFIC PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 ASIA-PACIFIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 37 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 38 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 39 ASIA-PACIFIC INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 40 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 42 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 44 JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 45 JAPAN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 46 JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 47 JAPAN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 48 JAPAN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 49 CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 50 CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 51 CHINA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 52 CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 53 CHINA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 54 CHINA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 55 INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 56 INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 57 INDIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 58 INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 59 INDIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 60 INDIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 61 SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 62 SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 63 SOUTH KOREA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 64 SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 65 SOUTH KOREA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 66 SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 68 AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 69 AUSTRALIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 70 AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 71 AUSTRALIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 72 AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 SINGAPORE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 74 SINGAPORE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 75 SINGAPORE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 76 SINGAPORE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 77 SINGAPORE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 78 SINGAPORE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 79 THAILAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 80 THAILAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 81 THAILAND INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 82 THAILAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 83 THAILAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 84 THAILAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 85 MALAYSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 86 MALAYSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 87 MALAYSIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 88 MALAYSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 89 MALAYSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 90 MALAYSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 91 INDONESIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 92 INDONESIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 93 INDONESIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 94 INDONESIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 95 INDONESIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 96 INDONESIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 97 PHILIPPINES NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 98 PHILIPPINES NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 99 PHILIPPINES INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 100 PHILIPPINES NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 101 PHILIPPINES NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 102 PHILIPPINES NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 103 VIETNAM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 104 VIETNAM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 105 VIETNAM INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 106 VIETNAM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 107 VIETNAM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 108 VIETNAM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions